Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01AI129731)
Article History
Received: 10 May 2025
Accepted: 26 February 2026
First Online: 30 March 2026
Competing interests
: T.D. is supported by a fellowship from Maze Therapeutics. N.Z. has roles in Qumae Biotechnologies and Dinamo Biotechnologies. The other authors declare no competing interests.